Pharmabiz20h
Pharma Literati launches course on ‘Patenting in Herbal, Ayush and Nutraceutical products’
Customized to the needs of students, researchers, academicians and industry professionals, Pharma Literati has recently launched India’s first course on ‘Patenting in Herbal, Ayush and Nutraceutical ...
Pharmabiz20h
BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation
BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation: Our Bureau, Mumbai Saturday, February 22, 2025, 08:00 Hrs [IST] Bio Asia, Asia's premier life sc ...
Pharmabiz20h
DGTR postpones oral hearing in anti-dumping probe on resorcinol imports from China and Japan
DGTR postpones oral hearing in anti-dumping probe on resorcinol imports from China and Japan: Shardul Nautiyal, Mumbai Saturday, February 22, 2025, 08:00 Hrs [IST] The Directorate ...
Pharmabiz20h
TN APTI to hold seminar on ‘Pioneering Pharmacy Profession’ at Dhanalakshmi University today
TN APTI to hold seminar on ‘Pioneering Pharmacy Profession’ at Dhanalakshmi University today: Peethaambaran Kunnathoor, Chennai Saturday, February 22, 2025, 08:00 Hrs [IST] In ...
Pharmabiz20h
India embarks on advanced research to thwart rising encephalitis cases
India embarks on advanced research to thwart rising encephalitis cases: Nandita Vijayasimha, Bengaluru Saturday, February 22, 2025, 08:00 Hrs [IST] India is intensifying research ...
Pharmabiz10h
SimonMed Imaging partners with HeartLung to offer AI-based bone density screening nationwide
SimonMed Imaging partners with HeartLung to offer AI-based bone density screening nationwide: Scottsdale, Arizon Saturday, February 22, 2025, 18:00 Hrs [IST] SimonMed Imaging, one ...
Pharmabiz12h
Bio-Techne introduces expanded menu of RNAscope probes for human and mouse transcriptome to advance spatial biology
Bio-Techne introduces expanded menu of RNAscope probes for human and mouse transcriptome to advance spatial biology: Minneapolis Saturday, February 22, 2025, 16:00 Hrs [IST] Bio-T ...
Pharmabiz11h
OS Therapies to receive US patent covering commercial manufacturing of OST-HER2
OS Therapies, Inc., a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced that it received a Notice of Allowance from the United ...
Pharmabiz17h
Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology: Basel Saturday, February 22, 2025, 11:00 Hrs [IST] Roche unveiled its pr ...
Pharmabiz15h
BioArctic’s global license agreement with Bristol Myers Squibb for PyroGlu-Aß antibody programme effective after antitrust clearance and closing
BioArctic’s global license agreement with Bristol Myers Squibb for PyroGlu-Aß antibody programme effective after antitrust clearance and closing: Stockholm, Sweden Saturday, Fe ...
Pharmabiz19h
Sobi & Apellis Pharma announces EMA validates indication extension application for Aspaveli for treatment of C3G and primary IC-MPGN
Stockholm, Sweden Saturday, February 22, 2025, 09:00 Hrs [IST] ...
Pharmabiz14h
Harbour BioMed, Insilico Medicine enter strategic collaboration to advance AI-driven antibody discovery and development
Harbour BioMed, Insilico Medicine enter strategic collaboration to advance AI-driven antibody discovery and development: Cambridge, Massachusetts Saturday, February 22, 2025, 14:0 ...